1981
DOI: 10.1055/s-2007-1023488
|View full text |Cite
|
Sign up to set email alerts
|

An Experimental Study on Transannular Patching of the Right Ventricular Outflow Tract with and without a Pulmonary Valve Monocusp Mechanism

Abstract: The efficacy of a pericardial patch in the right ventricular outflow tract (RVOT) with a monocusp valve mechanism was investigated experimentally. Hemodynamic performance of the right ventricle and angiographic competence of the valve were compared in animals after patching of the RVOT and removal of the pulmonary valve (group I), patching of the RVOT, removal of the pulmonary valve and implantation of a monocusp valve (group II), patching of the RVOT, partial removal of the pulmonary valve and implantation of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
8
0

Year Published

1984
1984
2009
2009

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 2 publications
0
8
0
Order By: Relevance
“…Different methods have been used to create a valve in the pulmonary artery annulus to resume the pulmonary valvular function. This includes valved homograft patch, 3,7 monocusp patch, 5,[13][14][15][16][17][18][19][20][21][22][23][24][25] or reconstructing an autologous competent 3-cusp valve from the native tissues. 26 We have demonstrated that when one pulmonary valve is absent in the pulmonary artery with the normal size, it creates a pulmonary regurgitation with back flow that equals to about half of the forward pulmonary artery flow.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Different methods have been used to create a valve in the pulmonary artery annulus to resume the pulmonary valvular function. This includes valved homograft patch, 3,7 monocusp patch, 5,[13][14][15][16][17][18][19][20][21][22][23][24][25] or reconstructing an autologous competent 3-cusp valve from the native tissues. 26 We have demonstrated that when one pulmonary valve is absent in the pulmonary artery with the normal size, it creates a pulmonary regurgitation with back flow that equals to about half of the forward pulmonary artery flow.…”
mentioning
confidence: 99%
“…There are a few types of monocusp patch being used for TOF repair. As reported, monocusps have been constructed from xenografts, homografts, fascia lata, and autologous pulmonary artery, pericardium, 5,[15][16][17][18][19][20][21][22][23][24][25][26] or Gore-Tex valve (W.L. Gore & Associates, Inc., Flagstaff, AZ, USA).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The second strategy, therefore, is to protect as far as possible the function of the native pulmonary valvar leaflets, or to create a new valve in pulmonary position when the transjunctional repair is inevitable. 13 Different methods have been used to create a new valve, including insertion of a valved homograft patch, 3,7 monocusp patches constructed from xenografts, homografts, fascia lata, autologous pulmonary artery, or pericardium, 5,[14][15][16][17][18][19][20][21][22][23][24][25][26][27] devices made of Gore-Tex, 28 or polytetrafluorethylene, 5,29 creation of a bifoliate polytetrafluoroethylene prosthesis, 30,31 or reconstruction of an autologous and competent trifoliate valve using native tissues. 26 We have recently described our own technique of creating an autologous pericardial monocusp patch containing 2 glutaraldehyde-treated pericardial patches.…”
mentioning
confidence: 99%
“…[30][31][32][33][34][35][36][37][38][39][40][41][42] Although initial effects of pulmonary insufficiency are well-tolerated, pulmonary insufficiency is probably not a benign lesion. ", 1*, 23,27,[43][44][45][46][47] Except for valve replacement, most intracardiac techniques to relieve valvular pulmonic stenosis cause some degree of valvular insufficiency.…”
Section: Discussionmentioning
confidence: 99%